NLRP3 and Sepsis: In addition, the system showed significant potential in reducing ROS production, suppressing NLRP3 expression, decreasing cardiomyocyte apoptosis, and improving survival in the sepsis model (Figure 8), illustrating the promising therapeutic effects of MSNs in sepsis‐related myocardial injury.